# OnCo record de-novo-protein-design (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/de-novo-protein-design/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "de-novo-protein-design" ;
  schema:name "De novo designed protein binders"@en ;
  schema:description "Designing a protein from scratch on a computer to grip a chosen target, instead of finding one in an animal or a library."@en ;
  schema:url <https://onco.cc/technologies/de-novo-protein-design/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?term=AI-designed%20antibody%20cancer> ;
  onco:status "phase-1" ;
  onco:tag "frontier", "promising" ;
  onco:sections <https://onco.cc/fronts/drug-discovery/>, <https://onco.cc/fronts/targeted-therapy/> ;
  onco:technologies <https://onco.cc/technologies/ai-drug-design/>, <https://onco.cc/technologies/adc/>, <https://onco.cc/technologies/radioligand-therapy/>, <https://onco.cc/technologies/peptide-drug-conjugate/>, <https://onco.cc/technologies/adc-payload-neutralizer/> ;
  onco:companies <https://onco.cc/companies/generate-biomedicines/>, <https://onco.cc/companies/isomorphic-labs/>, <https://onco.cc/companies/insilico-medicine/>, <https://onco.cc/companies/cradle-bio/>, <https://onco.cc/companies/profluent-bio/>, <https://onco.cc/companies/latent-labs/> .
